ArticleMedical oncology (Northwood, London, England)2010

Treatment of prostate and breast tumors employing mono- and bi-specific antisense oligonucleotides targeting apoptosis inhibitory proteins clusterin and bcl-2.

Marvin Rubenstein et al.PubMed ↗Publisher ↗

No numbers read from the abstract.